CAS: 169674-57-1; 5-Chloro-6-Fluoro-1H-Indole

相似化合物

376646-56-9 169673-92-1 122509-72-2

上下游产品

CAS号1097107-68-0 (4-chloro-5-flu... | CAS号875305-49-0 methyl (4-chlor... | CAS号1066-54-2 三甲基硅基乙炔 | CAS号169674-55-9 5-chloro-6-fluo...

(4-Chloro-5-Fluoro-2-Trimethylsilanylethynyl-Phenyl)-Carbamic Acid Methyl Ester置于四丁基氟化铵体系中,用 四氢呋喃 用作溶剂,化学反应 1.08H,以85%的收率获得5-氯-6-氟吲哚
参考文献:Indole,Indazole And Indoline Derivatives As Cetp Inhibitors
标题:Indole,Indazole And Indoline Derivatives As Cetp Inhibitors
摘要:本发明涉及以下式(I)的化合物: 其中-X-Y-,R1至r11和n如描述和权利要求中所定义,并且其药学上可接受的盐.这些化合物对于治疗和/或预防通过cetp抑制剂介导的疾病是有用的.

专利信息

专利号:WO-2020240272-A1
优先权日:2019-05-31
标题:Preparation of novel 1 h-pyrazolo[4,3-d]pyrimidines, their compositions, synthesis and methods of using them for treating tuberculosis
发明人：PAL MANOJIT; MISRA PARIMAL; SRIKANTAM APARNA; AHMAD FARHAN JALEES; EHTESHAM NASREEN ZAFAR; HASNAIN SEYED EHTESHAM
权利人:DR REDDYS INST OF LIFE SCIENCES; JAMIA HAMDARD UNIV
摘要:The present invention provides novel heterocyclic compounds of Formula (I): their derivatives, analogs, tautomeric forms, stereoisomers, bioisosters, diastereomers, polymorphs, enantiomers, prodrugs and their pharmaceutically acceptable salts for the treatment of tuberculosis. Also disclosed is the process for preparing compounds of Formula (I), and intermediates useful for preparing compounds of Formula (I).